Accuray CyberKnife

Image-guided radiosurgical ablation device earns FDA go-ahead for expanded indication covering use with "lesions, tumors and conditions anywhere in the body when radiation treatment is needed," the firm reports Oct. 1. Current stereotactic radiosurgery reimbursement coding for both inpatient and outpatient care is applicable to the CyberKnife procedure, previously cleared for head, neck and spine use